CAR-T cell therapy vs bispecific antibodies for pediatric relapsed B-ALL after second relapse: sequencing and selection?
Optimal Sequencing of Immunotherapy for Pediatric B-Cell Acute Lymphoblastic Leukemia with Second Relapse Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Clinical Consensus